Senior Research Scientist
AstraZeneca, United Kingdom
Holly has a broad range of experience applying analytical chemistry techniques to a variety of research projects. The majority of Holly's experience has been in the pharmaceutical industry having worked as an analytical chemist at GSK, Novartis and the MHRA, with roles based in drug discovery, process chemistry and final product testing. More recently Holly has worked at Owlstone Medical where she developed separation and detection methods for identifying volatile biomarkers in breath samples and the Francis Crick Institute where she was involved in the LC-MS investigation of the metabolomics and drug resistance of Mycobacterium tuberculosis.
Holly’s role at AstraZeneca is based within the Separation Sciences team and focusses on delivering rapid and sustainable analytical, purification and automation techniques to support Oncology chemistry.